logo
Share SHARE
FONT-SIZE Plus   Neg

BMY, Pfizer Records Consistent Results In Sub-analysis Of Eliquis Vs. Warfarin

Bristol-Myers Squibb Co. (BMY: Quote) and Pfizer Inc. (PFE: Quote) said the Phase III Aristotle trial of Eliquis in comparison with warfarin for the the prevention of stroke or systemic embolism in nonvalvular atrial fibrillation were consistent with the overall results of the Aristotle trial. Further, the companies said the Eliquis compared with warfarin reduced stroke or systemic embolism, caused fewer major bleeding events, and reduced all-cause mortality in NVAF patients with or without valvular heart disease or VHD.

The Aristotle trial excluded patients with clinically significant mitral stenosis, or a mechanical prosthetic heart valve.

The results of the sub analysis were presented in an oral session today at the ESC Congress 2013 in Amsterdam, The Netherlands.

The subanalysis evaluated Eliquis compared to warfarin in patients with or without other types of VHD, who were eligible for enrollment in the Aristotle

trial, including mitral regurgitation, mitral stenosis, aortic regurgitation, aortic stenosis, tricuspid regurgitation, or valve surgery. 4,808 patients participated in the sub analysis.

Eliquis is an oral inhibitor of blood clotting protein Factor Xa.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In a thumbs up for the Iceland bond market, investors strongly oversubscribed to a bench-marked bond offering by Arion Bank, as the Nordic island country warms up to possible easy access to international credit. Arion Bank issued bonds for 300 million euros and received bids of more than 675 million euros from about 100 investors. The bonds are 3-year instruments with a fixed 3.125 percent coupon. Pacific Investment Management Co. LLC, better known as PIMCO, said investors pulled $8.6 billion from its Total Return Fund in February, the lowest amount of monthly outflow since departure of bond guru Bill Gross last year. The outflows for the month of February from Pimco's flagship fund dropped... Sony said it plans to release its virtual-reality headset next year, giving gamers something more to cheer about when using their playstation 4 console.
comments powered by Disqus
Follow RTT